Oruka Therapeutics, Inc. (ORKA)
NASDAQ: ORKA · Real-Time Price · USD
73.99
-2.40 (-3.14%)
At close: Apr 28, 2026, 4:00 PM EDT
74.25
+0.26 (0.35%)
After-hours: Apr 28, 2026, 7:58 PM EDT
Oruka Therapeutics Analyst Ratings
Total Analysts
12
Consensus Rating
Strong Buy
Price Target
$88.33
Upside
+19.38%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Strong Buy Maintains $75 → $100 | Strong Buy | Maintains | $75 → $100 | +35.15% | Apr 28, 2026 |
| Barclays | Barclays | Buy Maintains $78 → $160 | Buy | Maintains | $78 → $160 | +116.25% | Apr 28, 2026 |
| BTIG | BTIG | Strong Buy Maintains $78 → $151 | Strong Buy | Maintains | $78 → $151 | +104.08% | Apr 27, 2026 |
| Wedbush | Wedbush | Buy Maintains $45 → $85 | Buy | Maintains | $45 → $85 | +14.88% | Apr 15, 2026 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $125 | Strong Buy | Reiterates | $125 | +68.94% | Apr 13, 2026 |
| BTIG | BTIG | Strong Buy Maintains $73 → $78 | Strong Buy | Maintains | $73 → $78 | +5.42% | Apr 13, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $40 → $70 | Strong Buy | Maintains | $40 → $70 | -5.39% | Apr 13, 2026 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $125 | Strong Buy | Reiterates | $125 | +68.94% | Apr 9, 2026 |
| Barclays | Barclays | Buy Maintains $50 → $78 | Buy | Maintains | $50 → $78 | +5.42% | Apr 7, 2026 |
| UBS | UBS | Strong Buy Maintains $50 → $75 | Strong Buy | Maintains | $50 → $75 | +1.37% | Apr 6, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $60 → $125 | Strong Buy | Maintains | $60 → $125 | +68.94% | Apr 6, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $58 → $86 | Buy | Maintains | $58 → $86 | +16.23% | Mar 16, 2026 |
| Barclays | Barclays | Buy Maintains $48 → $50 | Buy | Maintains | $48 → $50 | -32.42% | Mar 13, 2026 |
| BTIG | BTIG | Strong Buy Reiterates $73 | Strong Buy | Reiterates | $73 | -1.34% | Mar 13, 2026 |
| Stifel | Stifel | Strong Buy Maintains $47 → $72 | Strong Buy | Maintains | $47 → $72 | -2.69% | Mar 13, 2026 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | -18.91% | Mar 13, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.